1. |
Lin J,Lin E,Nemunaitis J.Bacteria in the treatment of cancer[J].Curr Opin Mol Ther,2004,6(6):629-639..
|
2. |
Ryan RM,Green J,Lewis CE.Use of bacteria in anticancer therapies[J].Bioessays,2006,28(1):84-94..
|
3. |
Tokunaga T,Yamamoto H,Shimada S,et al.Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG.Ⅰ.Isolation,physicochemical characterization,and antitumor activity[J].J Natl Cancer Inst,1984,72(4):955-962..
|
4. |
Ballas ZK,Rasmussen WL,Krieg AM.Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA[J].J Immunol,1996,157(5):1840-1845..
|
5. |
Bauer M,Heeg K,Wagner H,et al.DNA activates human immune cells through a CpG sequencedependent manner[J].Immunology,1999,97(4):699-705..
|
6. |
Krieg AM.CpG motifs in bacterial DNA and their immune effects[J].Annu Rev Immunol,2002,20:709-760..
|
7. |
Krieg AM,Wagner H.Causing a commotion in the blood:immunotherapy progresses from bacteria to bacterial DNA[J].Immunol Today,2000,21(10):521-526..
|
8. |
Krieg AM,Yi AK,Matson S,et al.CpG motifs in bacterial DNA trigger direct Bcell activation[J].Nature,1995,374(6522):546-549..
|
9. |
Paterson Y,Maciag PC.Listeriabased vaccines for cancer treatment[J].Curr Opin Mol Ther,2005,7(5):454-460.
|
10. |
Reed JC.Bcl2 and the regulation of programmed cell death[J].J Cell Biol,1994,124(1-2):16..
|
11. |
Oltvai ZN,Milliman CL,Korsmeyer SJ.Bcl2 heterodimerizes in vivo with a conserved homolog,Bax,that accelerates programmed cell death[J].Cell,1993,74(4):609-619..
|
12. |
Fisher TC,Milner AE,Gregory CD,et al.bcl2 modulation of apoptosis induced by anticancer drugs:resistance to thymidylate stress is independent of classical resistance pathways[J].Cancer Res,1993,53(14):3321-3326..
|
13. |
Sparwasser T,Koch ES,Vabulas RM,et al.Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells[J].Eur J Immunol,1998,28(6):2045-2054..
|
14. |
Stacey KJ,Sweet MJ,Hume DA.Macrophages ingest and are activated by bacterial DNA[J].J Immunol,1996,157(5):2116-2122..
|
15. |
Cowdery JS,Chace JH,Yi AK,et al.Bacterial DNA induces NK cells to produce IFNγ in vivo and increases the toxicity of lipopolysaccharides[J].J Immunol,1996,156(12):4570-4575..
|
16. |
Heckelsmiller K,Rall K,Beck S,et al.Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model[J].J Immunol,2002,169(7):3892-3899..
|
17. |
Yamamoto S,Yamamoto T,Shimada S,et al.DNA from bacteria,but not from vertebrates,induces interferons,activates natural killer cells and inhibits tumor growth[J].Microbiol Immunol,1992,36(9):983-997..
|
18. |
Stacey KJ,Young GR,Clark F,et al.The molecular basis for the lack of immunostimulatory activity of vertebrate DNA[J].J Immunol,2003,170(7):36143620..
|
19. |
Pamer EG.Immune responses to Listeria monocytogenes[J].Nat Rev Immunol,2004,4(10):812823..
|
20. |
戴智勤,朱为.细菌载体技术研究进展(上)[J].国外医学预防诊断治疗用生物制品分册,2005,28(1):14-17.
|